Email me when a study starts taking inquiries

1Your information
2Confirmation

Ask to be emailed when a listed study starts screening. Not a referral and not a place on a study list.

You are asking for an email when a study starts taking inquiries. You are not referring a patient. You can stop the emails from any message we send.

Fields marked * are required.

What is your name? *

What is your work email? *

A clinic or health system email is best.

Organization *

Role *

Email me when which studies change? *

Psilocybin for Transdiagnostic Psychiatry SymptomsSynaptotrophic Effects of Psilocybin in Opioid Use DisorderPsilocybin Therapy for Depression in Parkinson's Disease (PSI-PD)Young Adult Study — Psilocybin for Treatment-Resistant OCDGroup Study — Psilocybin for a Psychiatric Condition (TBD)

Check any.

Also email me when a study stops taking inquiries?

YesNo

Stop these emails — every message we send has a link to stop; there is nothing to set here.

What happens next: We email only when a study you picked starts or stops taking inquiries.

Prefer to reach us directly? Write to enact@enactresearch.com or call (203) 444-1795.

Email me when a study starts taking inquiries.